Author

Bharti Mittal

The Pirbright InstituteORCID 0000-0003-2493-8936Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Bharti Mittal1 paper · Avesthagen (India)

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:plant (other)· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Basudev PaudyaliD· 1 shared Charlotte May· 1 shared Christine S. RollieriD· 1 shared Cornelis A. M. de HaaniD· 1 shared Danish MuniriD· 1 shared Debkishore Gupta· 1 shared Ehsan Sedaghat-RostamiiD· 1 shared Elma Z. TchilianiD· 1 shared

Activity by Year

2020-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Basudev PaudyalORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyDiscovery ImmunologyPeer-reviewedOct 23, 2026

Infection drives localised and individualised antibody repertoires, whereas immunisation promotes repertoire convergence in pig

Emily Briggs, Shafiyeel Chowdhury, Bharti Mittal…·Elma Z. Tchilian

This study compares antibody repertoires in pigs after infection and immunisation, finding infection drives compartmentalised, individualised responses while immunisation promotes convergent, public repertoires.

DOI 10.1093/discim/kyag020

plant (other)proteomics

𝕏 PostBluesky

BioinformaticsbioRxivPreprintJul 23, 2020

Immuno-informatics approach for multi-epitope vaccine designing against SARS-CoV-2

Souvik Banerjee, Kaustav Majumder, Gerardo Jose Gutierrez…·Bharti Mittal

This paper designs a multi-epitope vaccine against SARS-CoV-2 using immuno-informatics, showing it is stable, non-allergic, and antigenic with strong immune responses.

39 citations

statistical modeldrug response / drug discovery

𝕏 PostBluesky